William Hagstrom is the founder and CEO of Octave, a leading neuroscience precision care company dedicated to improving patient lives and outcomes, starting by addressing the significant unmet needs facing those living with multiple sclerosis. Previously, he served as the CEO of Crescendo Bioscience which created novel measurement tools and software in the field of rheumatology. William has more than 25 years of start-up experience in a broad range of medical specialties intersecting science, technology, clinical medicine, and business strategy.
Precision medicine for neurodegenerative conditions has the potential to radically change the way patients are treated and managed over time. As an industry, we must continue to expand our thinking and push the boundaries of science, technology, and data analytics to capture precision medicine opportunities in broader areas of unmet medical needs.